Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 1, 2016
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
[ Mon, Aug 01st 2016
] - WOPRAI
Fri, July 29, 2016
[ Fri, Jul 29th 2016
] - WOPRAI
[ Fri, Jul 29th 2016
] - WOPRAI
[ Fri, Jul 29th 2016
] - WOPRAI
[ Fri, Jul 29th 2016
] - WOPRAI
[ Fri, Jul 29th 2016
] - WOPRAI
[ Fri, Jul 29th 2016
] - WOPRAI
[ Fri, Jul 29th 2016
] - WOPRAI
[ Fri, Jul 29th 2016
] - WOPRAI
[ Fri, Jul 29th 2016
] - WOPRAI
[ Fri, Jul 29th 2016
] - WOPRAI
Jessica Fye Maintained (UTHR) at Hold with Decreased Target to $129 on, Jul 29th, 2016
Jessica Fye of JP Morgan, Maintained "United Therapeutics Corporation" (UTHR) at Hold with Decreased Target from $145 to $129 on, Jul 29th, 2016.
Jessica has made no other calls on UTHR in the last 4 months.
There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, all agree with Jessica's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Andrew Fein of "HC Wainwright & Co." Downgraded from Strong Buy to Hold and Decreased Target to $95 on, Wednesday, June 15th, 2016
- Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Tuesday, May 24th, 2016
- Matthew Kaplan of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Friday, April 29th, 2016
